Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
1000 participants
INTERVENTIONAL
2024-02-25
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adult Trauma Centers RE-AIM at Gun Safety
NCT06302452
Reframing Firearm Injury Prevention Through Bystander Interventions for Youth
NCT04804189
Nationwide Study of Firearm Violence Prevention Tactics and Policies in K-12 Schools
NCT05552716
Pediatric Inpatient Firearm Safety Study
NCT03077646
Practice Facilitation to Enhance Implementation of a Pediatric Suicide Prevention Pathway
NCT06619782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
In the pre-implementation period, all trauma patients will receive standard routine care. Which may include some screening and counseling on gun safety.
No interventions assigned to this group
ACTFAST Intervention
During the implementation and maintenance periods, all trauma patients will receive study activities including firearm access screening, counseling on safe storage practices, and referral to safe storage and other community resources as appropriate.
Adopting Comprehensive Training for FireArm Safety in Trauma centers
Firearm access screening, brief firearm safe storage intervention, and referral to community and preventive health resources
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adopting Comprehensive Training for FireArm Safety in Trauma centers
Firearm access screening, brief firearm safe storage intervention, and referral to community and preventive health resources
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be fluent in English or Spanish
* Must be between the ages of 11-17 years
* admitted to a participating trauma inpatient service for an injury
* fluent in English or Spanish
* able to provide written assent and parent able to provide written consent
Exclusion Criteria
For youth trauma patients:
* Youth who are prisoners or in police custody
* Youth who are admitted due to suicide attempt
* Youth with acute conditions that would preclude provision of informed consent (i.e., acute psychosis, altered mental status, cognitive impairment)
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Centers for Disease Control and Prevention
FED
Children's Hospitals and Clinics of Minnesota
OTHER
University of Utah
OTHER
Rhode Island Hospital
OTHER
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine Hoops, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Medicine
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE003620
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB00407213
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.